Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Evaxion Biotech A/S
13G/A
EVAX · 29970R204
|
20.0% |
2/3/2025
Event 1/31/2025
|
|||
| Merck & Co., Inc. | 20.0% | ||||
| Merck Sharp & Dohme LLC | 20.0% | ||||
| Merck Global Health Innovation Fund, LLC | 20.0% | ||||
|
Personalis, Inc.
13G
PSNL · 71535D106
|
16.5% |
12/23/2024
Event 12/19/2024
|
|||
| Merck & Co., Inc. | 16.5% | ||||
| Merck Sharp & Dohme LLC | 16.5% | ||||